Reneuron Share Chat (RENE)

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Reneuron Group	LSE:RENE	London	Ordinary Share	GB00B0DZML60	ORD 1P

	Price Change	% Change	Share Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	+0.00p	+0.00%	1.75p	1.70p	1.80p	1.75p	1.75p	1.75p	987,644	08:00:00

Industry Sector	Turnover (m)	Profit (m)	EPS - Basic	PE Ratio	Market Cap (m)
Pharmaceuticals & Biotechnology	0.0	-18.2	-0.5	-	55.29

Reneuron Share Discussion Threads

Showing 5426 to 5448 of 5450 messages

Chat Pages: 218 217 216 215 214 213 212 211 210 209 208 207 Older

Date	Subject	Author	Discuss
26/7/2017 14:03	No placing; Shake up the register and wake up the dead.	norbus	Read Full Thread Reply
25/7/2017 18:34	New joint broker = placing?	127tolmers	Read Full Thread Reply
05/7/2017 18:30	Out all day and missed one of the few up days.	dickbush	Read Full Thread Reply
05/7/2017 17:21	Good god. It's going up. 0.4p a share up on my last purchase.	yachtmaster2	Read Full Thread Reply
04/7/2017 08:51	Thanks,algernon2 A very professional and positive presentation. However, he and the company seem to continue to have a major credibility problem-as judged by the share price. Despite record highs for the stockmarket, the share price is at an all-time low with holders, apparently, willing to sell no matter what the bid price.	dickbush	Read Full Thread Reply
03/7/2017 20:59	"It's 'all systems go' as ReNeuron gears up for Phase III stroke disability study" hTTps://www.youtube.com/watch?v=QJaKk3F-TQs	algernon2	Read Full Thread Reply
30/6/2017 10:22	Hi Algernon.	fredd1eboy	Read Full Thread Reply
30/6/2017 10:18	Hello Freddie.	algernon2	Read Full Thread Reply
29/6/2017 18:24	Seems like all tech shares are being hit by a bubble in some... D	dennisbergkamp	Read Full Thread Reply
29/6/2017 18:21	Agreed, Verger. I'm not sure, as the presentation claims, that they are ahead of competition in all of their areas of interest. However, it was a good presentation, I thought, although my level of expertise in biotec is minimal. The shares are my speculation in an exciting area. I know what the downside is!	dickbush	Read Full Thread Reply
29/6/2017 18:06	Or you could say that no value is being given to its potential. This is silly.	verger	Read Full Thread Reply
29/6/2017 17:35	Shares being valued at its cash. No value, therefore, being assigned to all the clinical work that has taken place so far.	dickbush	Read Full Thread Reply
29/6/2017 10:22	'Results' are a list of projects being worked on. The real news - or results really - come at times when they discover something or someone offers money. The consequence of today's RNS , so far, is that the share price trajectory is maintaining its 'going down the drain' path.Of course that can change suddenly, & I certainly hope it will .	dogwalker	Read Full Thread Reply
29/6/2017 09:54	Any thoughts on results today? Missed the presentation too ;-( D	dennisbergkamp	Read Full Thread Reply
28/6/2017 17:22	I know good after bad etc.	yachtmaster2	Read Full Thread Reply
28/6/2017 17:21	I bought a lot for a very small amount of money yesterday afternoon. Went through as a sell	yachtmaster2	Read Full Thread Reply
28/6/2017 16:44	ReNeuron CFO Michael Hunt will be presenting to investors at the Proactive One2One Forum on the evening of 13th July in London. For details and registration, click here: https://tinyurl.com/ya62szgf	aim_trader	Read Full Thread Reply
26/6/2017 13:45	Just bought a few at 1.799 pence at 13.35 for those interested to see if it later indicated it was a buy or a sell.I see plenty of potential upside medium term at this price.Here's to us Freddie and our pension fund. "Per Ardua Ad Astra" and chocks away! Edit: appears to be indicated as a sell on all the share platforms I looked at just now.	algernon2	Read Full Thread Reply
19/6/2017 19:36	Another piece of the jigsaw.I doubt it'll be catalyst for a sustained rise in the share price ....more likely to see it meander at 2p for while	audigger	Read Full Thread Reply
19/6/2017 10:27	Huge potential here, but the market has been bitten to many times by jam tomorrow AIM companies. Although RENE have cash now, its not enough to take these therapies through to commercialisation, even if they do get approval. That's the problem with the share price. I'll continue on the side lines for the time being GLA.	johnb5	Read Full Thread Reply
19/6/2017 09:47	FDA Approval is huge. Healthcare in the US is a huge business as its mainly private and paid out for through the huge insurance premiums they have to pay. This really should be flying / taken out by a bigger player. D.	dennisbergkamp	Read Full Thread Reply
19/6/2017 09:30	It looks like everyone's on early hols across the entire market. Sleepy volumes everywhere.	small crow	Read Full Thread Reply
19/6/2017 09:20	FDA Approval for their hRPC ophthamology formulation and still not much activity... Incredible!	dennisbergkamp	Read Full Thread Reply

Chat Pages: 218 217 216 215 214 213 212 211 210 209 208 207 Older